|
[1]
|
Effect of loss-of-function CYP2C19 variants on clinical outcomes in coronary artery disease patients treated with clopidogrel: A systematic meta-analysis approach
International Journal of Cardiology,
2024
DOI:10.1016/j.ijcard.2024.132418
|
|
|
|
|
[2]
|
The efficacy of clopidogrel in preventing recurrent cardiovascular events among Arab population carrying different CYP2C19 mutations: systematic review and meta-analysis
Egyptian Journal of Medical Human Genetics,
2022
DOI:10.1186/s43042-022-00313-w
|
|
|
|
|
[3]
|
Antiplatelet response to clopidogrel is associated with a haplotype in CYP2C19 gene in Pakistani patients
Scientific Reports,
2022
DOI:10.1038/s41598-022-09679-8
|
|
|
|
|
[4]
|
The CYP2C19 genotypes and its effect on clopidogrel as an anti-platelet drug among the Arab population
Indian Journal of Pharmacology,
2021
DOI:10.4103/ijp.IJP_690_20
|
|
|
|
|
[5]
|
The CYP2C19 genotypes and its effect on clopidogrel as an anti-platelet drug among the Arab population
Indian Journal of Pharmacology,
2021
DOI:10.4103/ijp.IJP_690_20
|
|
|
|
|
[6]
|
Clinical and genetic influencing factors on clozapine pharmacokinetics in Tunisian schizophrenic patients
The Pharmacogenomics Journal,
2021
DOI:10.1038/s41397-021-00231-x
|
|
|
|
|
[7]
|
The clinical effects of CYP2C19 *2 allele frequency on Palestinian patients receiving clopidogrel after percutaneous coronary intervention
International Journal of Clinical Pharmacy,
2019
DOI:10.1007/s11096-018-00782-3
|
|
|
|
|
[8]
|
Allele frequency distribution of CYP2C19*2 allelic variants associated with clopidogrel resistance in cardiac patients
Experimental and Therapeutic Medicine,
2015
DOI:10.3892/etm.2015.2493
|
|
|
|